Back to Search
Start Over
The Use of Mobile Applications Among Adults with Type 1 and Type 2 Diabetes: Results from the Second MILES-Australia (MILES-2) Study.
- Source :
-
Diabetes technology & therapeutics [Diabetes Technol Ther] 2017 Dec; Vol. 19 (12), pp. 730-738. Date of Electronic Publication: 2017 Oct 13. - Publication Year :
- 2017
-
Abstract
- Background: While the number of diabetes-specific mobile applications (apps) continues to grow, there is a lack of knowledge about their actual use.<br />Methods: The second MILES (Management and Impact for Long-term Empowerment and Success)-Australia study was a national cross-sectional survey of the psychological, behavioral, and social aspects of diabetes for adults with type 1 diabetes (T1D) and type 2 diabetes (T2D). Associations between diabetes-specific app usage and demographic, clinical, and psychosocial variables were examined.<br />Results: Of the 1589 respondents responding to the diabetes-specific app questions, 795 had T1D (mean ± standard deviation age 43 ± 14 years; 61% women; diabetes duration 19 ± 14 years) and 794 had T2D (age 60 ± 9 years; 40% women; diabetes duration 11 ± 7 years). Among adults with T1D, 24% (n = 188) reported using apps, with carbohydrate counting (74%; n = 139) as the most common cited purpose. App usage was significantly associated with shorter diabetes duration, more frequent glucose monitoring, and lower self-reported HbA1c. Among adults with T2D, 8% (n = 64) reported using apps, with glucose monitoring (62%; n = 39) as the most common purpose. For all respondents, the most commonly reported reason for not using apps was a belief that they could not help with diabetes self-management.<br />Conclusions: A minority of adults with T1D and T2D use apps to support their self-management. App use among adults with T1D is associated with a more recent T1D diagnosis, more frequent glucose monitoring, and lower self-reported HbA1c. Future efforts should focus on this association and determine the mechanisms by which app use is related to better clinical outcomes.
Details
- Language :
- English
- ISSN :
- 1557-8593
- Volume :
- 19
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Diabetes technology & therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 29028442
- Full Text :
- https://doi.org/10.1089/dia.2017.0235